The Ordinary Skin Care

The Ordinary is a disruptive skincare brand founded in Toronto, Canada, in 2016. It gained global fame for its "Clinical Formulations with Integrity," offering high-quality active ingredients at significantly lower price points than traditional luxury brands. The brand's focus on transparency and science-driven results revolutionized the beauty industry by educating consumers on specific ingredients like Niacinamide and Hyaluronic Acid.

While the brand was originally developed under the DECIEM umbrella (The Abnormal Beauty Company), it has since transitioned through a major acquisition. Today, the products are primarily manufactured in Canada at DECIEM's facilities. The brand is now a key pillar of the Estée Lauder Companies' portfolio, following a multi-year acquisition process completed in 2024.